Rennes - CHU

Running trials

• Not yet recruiting

  Stroke Cerebral Reorganization Pathways (SPECTRE)

  NCT06784518· Source

• Recruiting

  Trial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus Chemotherapy in Patients With Pleural Mesothelioma

  NCT07234058· Phase 2· Source

• Recruiting

  Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced, Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinomas (NECs)

  NCT06937905· Phase 3· Source

• Recruiting

  earlY Upper Limb Rehabilitation WIth EEG-Neurofeedback After Stroke

  NCT05884762· Source

• Recruiting

  A Prospective Cohort Study to Evaluate Molecular pRognostic Factors and Resistance Mechanisms to Osimertinib in Adjuvant Treatment of Completely Resected pIB-IIIA Non-small Cell Lung Carcinoma With Common EGFR Mutations (L858R and Del19)

  NCT06053099· Source

• Recruiting

  Epidemiological Study of a Prospective Cohort of Patients Aged 60 and Over Managed for Acute Myeloid Leukemia (AML) and Receiving Intensive Induction Therapy

  NCT06891144· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer3 recruiting
• Stroke2 recruiting
• Acute myeloid leukemia1 recruiting
• Mesothelioma1 recruiting
• Neuroendocrine tumours1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Her2-positive Lung Cancer Treated With Dedicated Drug

  NCT03845270· Phase 2· Source